Consistent with the above conclusions, this study also confirmed that MYC protein overexpression was associated with inferior OS and PFS and exhibited a worse response to treatment in patients with bulky mass DLBCL. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.